AzTrials
AzTrials

Molar Incisor HypomineralizationMIhCFAONCT04922177

Computer-aided Design/Computer-aided Manufacturing for Mild to Moderate Molar Incisor Hypomineralization Treatment

A study testing Indirect ceramic restoration and Direct restoration in people with Molar Incisor Hypomineralization, run by University Hospital, Toulouse at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Molar Incisor Hypomineralization (MIH) is a disease causing a structural defect in the enamel of permanent teeth. The treatment of these teeth consists of the removal of the affected part of the tooth and its reconstitution. Classically, the restoration is done with a resin in direct method. Read more about this study

Who is it for?
Ages 7 to 12 years
Conditions the study is for
Molar Incisor Hypomineralization
What is being tested?
Indirect ceramic restoration and Direct restoration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteFrance
Study dates
Jun 2021to Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child from 7 to 12 years old presenting a mild to moderate HIN on at least one permanent first molar requiring reconstitution.
  • Child presenting a state of anxiety compatible with the provision of oral care (score on the Venham scale modified by Veerkamp below 2).
  • Child affiliated to or benefiting from a social security scheme.
  • Free, informed and signed consent by the parent(s)/holder(s) of parental authority and the investigator (at the latest on the day of inclusion and before any examination required by the research).
  • Oral consent of the child.
  • Non-inclusion criteria:
Show all 11Show fewer
  • Child presenting an allergy or a history of allergy to one of the constituents of biomaterials
  • Child with fluorosis
  • Child with amelogenesis imperfecta
  • Child with pacemaker (contraindication to CAD/CAM)
  • -

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • University hospital of Toulouse

    Toulouse, 31062

    Mathieu Marty, marty.mat@chu-toulouse.fr

    Mathieu Marty

Other trials in France

About this study

Official title: Computer-aided Design/Computer-aided Manufacturing for Mild to Moderate Molar Incisor Hypomineralization Treatment : a Pilot Study

Molar Incisor Hypomineralization (MIH) is a disease causing a structural defect in the enamel of permanent teeth. The treatment of these teeth consists of the removal of the affected part of the tooth and its reconstitution. Classically, the restoration is done with a resin in direct method. With the development of Computer-aided design (CAD) and Computer-aided manufacturing (CAM), it is possible to make a custom-made part to replace the affected part of the tooth. The main objective is to describe the effect of the 6-month management of CAD/CAM type restorations compared to direct restorations, performed in children aged 7 to 12 years with mild to moderate MIH on permanent molar teeth.

Read the detailed description

Molar Incisor Hypomineralization (MIH) is a structural defect of the enamel affecting at least one of the first four permanent molars. The prevalence is high, ranging from 20% to 40% of children. The consequences of MIH are multiple, including pain during food intake or an increased risk for the development of carious disease. The current standard protocol for mild to moderate MIH is the use of direct restorations (Glass Cement Ionomer type). However, this therapy is not suitable due to frequent failures. In terms of longevity, indirect restorations are superior to direct restorations. CAD/CAM in dentistry offers the possibility of making these inlay/onlay type perennial coronary restorations. It is faster to implement and does not require a conventional impression.

Being tested
Indirect ceramic restoration, Direct restoration
Keywords
Molar Incisor Hypomineralization, Direct restauration, Computer-aided design (CAD), Computer-aided manufacturing (CAM)
Medical subject headings
Molar Hypomineralization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect ceramic restorationProcedure or surgery

    Indirect ceramic restoration using an optical impression.

  • Direct restorationProcedure or surgery

    Restoration using a Glass Ionomer Cement

Study groups in NCT04922177
Study groupRoleWhat they receive
CAD/CAM GroupExperimentalFor the CAD/CAM group, an indirect ceramic restoration will be made using an optical impression.
Receives: Procedure: Indirect ceramic restoration
Direct method GroupActive comparatorFor the direct method group, a restoration using a Glass Ionomer Cement will be performed.
Receives: Procedure: Direct restoration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment effect

    The effect of the management of the MIH will be assessed by the occurrence of failure. Failure will be diagnosed from the degree of demineralisation measured, by laser fluorescence at the peripheral tooth/restoration joint. The values collected range from 0 to 99 and are categorised into 3 situations :

    • From 0 to 12: situation without demineralization, tight seal.
    • From 13 to 24: start of demineralization
    • ≥ 25: therapeutic failure, non-watertight seal, restoration to be redone without delay.

    Measured: 6 months

Secondary outcomes (2)
  1. Failure

    Failure diagnosed according to the degree of demineralisation measured, every 3 months following the restoration, by laser fluorescence at the peripheral tooth/restoration joint.

    Measured: 3 months

  2. Failure

    Failure diagnosed according to the degree of demineralisation measured, every 12 months following the restoration, by laser fluorescence at the peripheral tooth/restoration joint.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2021
  2. Study startJun 2021 (estimated)
  3. Primary completionJun 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
68 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04922177
Sponsor's protocol ID
RC31/19/0053
Acronym
MIhCFAO
Status last verified
Jun 2021
First submitted
4 Jun 2021
Last updated
10 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Indirect ceramic restoration and Direct restoration in people with Molar Incisor Hypomineralization, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mathieu MARTY (06.79.97.47.11, marty.mat@chu-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment effect (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in